A speedy new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL (University College London) researchers.
Hay fever, also known as allergic rhinitis, is the condition responsible for seasonal allergies or allergic reactions to other environmental allergens, like dust mites and animal dander. Ultimately, these symptoms disrupt daily activities and affect quality of life for hay fever sufferers.
BD Surgiphor™ is a sterile, ready-to-use irrigation solution designed to help loosen and remove debris from surgical wounds during procedures
Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to research presented at the annual meeting of the Radiological Society of North America (RSNA).
New computer modeling could help scientists better understand how the retina regenerates, opening the door to new treatments for vision loss, according to a study from the University of Surrey.
Scientists at the University of Portsmouth have created the first detailed 3D map of how a crucial piece of connective tissue in our bodies responds to the stresses of movement and exercise. This tissue, called calcified fibrocartilage (CFC), acts like a biological shock absorber where tendons attach to bone.
New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows
PITTSBURGH , Nov. 25, 2025 /PRNewswire/ — “I thought there should be a way for my wife to get a restful night of sleep while still pumping to maintain the milk supply for feeding our baby,” said an inventor, from Campbellsburg, Ky., “so I invented the AUTO – PUMPING BRA WITH TIIMER FUNCTION. My design helps exhausted moms by eliminating the need to choose between pumping and sleeping.”
NEW YORK, Nov. 25, 2025 /PRNewswire/ — Nucs AI, the leader in AI-based radiology solutions, today announced the launch of TrackPSMA, a breakthrough tool that gives physicians a faster, quantitative way to evaluate treatment response in prostate cancer.
PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has expanded the indication for the Bracco-branded Max 3™, a Rapid Exchange and Syringeless Injector for use in magnetic resonance imaging (MRI) procedures. In addition to single-dose and multi-dose vials, the Max 3™ system is now indicated for use with the newly approved VUEWAY® (gadopiclenol) injection Imaging Bulk Package (IBP) in 30 mL and 50 mL formats.